The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology: IN VITRO PHARMACOLOGY OF SDZ ASM 981
Abstract
SDZ ASM 981, a novel ascomycin macrolactam derivative, has high anti-inflammatory activity in animal models of allergic contact dermatitis and shows clinical efficacy in atopic dermatitis, allergic contact dermatitis and psoriasis, after topical application. Here we report on the in vitro activities of this promising new drug. SDZ ASM 981 inhibits the proliferation of human T cells after antigen-specific or non-specific stimulation. It downregulates the production of Th1 [interleukin (IL)-2, interferon-gamma] and Th2 (IL-4, IL-10) type cytokines after antigen-specific stimulation of a human T-helper cell clone isolated from the skin of an atopic dermatitis patient. SDZ ASM 981 inhibits the phorbol myristate acetate/phytohaemagglutinin-stimulated transcription of a reporter gene coupled to the human IL-2 promoter in the human T-cell line Jurkat and the IgE/antigen-mediated transcription of a reporter gene coupled to the human tumour necrosis factor (TNF)-alpha promoter in the murine mast-cell line CPII. It does not, however, affect the human TNF-alpha promoter controlled transcription of a reporter gene in a murine dendritic cell line (DC18 RGA) after stimulation via the FcgammaRIII receptor. SDZ ASM 981 also prevents the release of preformed pro-inflammatory mediators from mast cells, as shown in the murine cell line CPII after stimulation with IgE/antigen. In summary, these results demonstrate that SDZ ASM 981 is a specific inhibitor of the production of pro-inflammatory cytokines from T cells and mast cells in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Jaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 6,856
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
The determination of enzyme inhibitor constants
Dixon, M. (1953) · Biochemical Journal · doi:10.1042/bj0550170 · Cited by 4,069
Pène, J., Rousset, F., Brière, F., Chrétien, I., Bonnefoy, J. Y., Spits, H., Yokota, T., Arai, N., Arai, K., & Banchereau, J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6880 · Cited by 924
Gottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
Dumont, F. J., Staruch, M. J., Koprak, S. L., Melino, M. R., & Sigal, N. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.251 · Cited by 603
Liu, J., Albers, M. W., Wandless, T. J., Luan, S., Alberg, D. G., Belshaw, P. J., Cohen, P., MacKintosh, C., Klee, C. B., & Schreiber, S. L. (1992) · Biochemistry · doi:10.1021/bi00131a002 · Cited by 558
Ullman, K. S., Northrop, J. P., Verweij, C. L., & Crabtree, G. R. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.002225 · Cited by 503
T Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset
Schlaak, J. F., Buslau, M., Jochum, W., Hermann, E., Girndt, M., Gallati, H., Büschenfelde, K.-H. M. Z., & Fleischer, B. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371752 · Cited by 455
Cited by
Atopic dermatitis: New insights and opportunities for therapeutic intervention
Leung, D. Y. M. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106484 · Cited by 721
Jiaravuthisan, M. M., Sasseville, D., Vender, R. B., Murphy, F., & Muhn, C. Y. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.07.073 · Cited by 416
Eichenfield, L. F., Lucky, A. W., Boguniewiczc, M., Langley, R. G. B., Cherille, R., Marshalle, K., Bushe, C., & Graeber, M. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122187 · Cited by 366
S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update
Nast, A., Boehncke, W., Mrowietz, U., Ockenfels, H., Philipp, S., Reich, K., Rosenbach, T., Sammain, A., Schlaeger, M., Sebastian, M., et al. (2012) · JDDG: Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07919.x · Cited by 272
Kapp, A., Papp, K., Bingham, A., Fölster-Holst, R., Ortonne, J.-P., Potter, P. C., Gulliver, W., Paul, C., Molloy, S., Barbier, N., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.126500 · Cited by 272
Metadata
- Authors
- Grassberger, Baumruker, Enz, Hiestand, Hultsch, Kalthoff, Schuler, Schulz, Werner, Winiski, Wolff, & Zenke
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 141
- Issue
- 2
- Pages
- 264-273
- ISSN
- 0007-0963 (ISSN-L)
- OpenAlex
- W1534735809
- Cited by
- 267
- References
- 30
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology: IN VITRO PHARMACOLOGY OF SDZ ASM 981. https://app.cochat.ai/papers/10.1046/j.1365-2133.1999.02974.x
- The paper
- Grassberger, Baumruker, Enz, Hiestand, Hultsch, Kalthoff, Schuler, Schulz, Werner, Winiski, Wolff, & Zenke. (1999). A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology: IN VITRO PHARMACOLOGY OF SDZ ASM 981. British Journal of Dermatology. https://doi.org/10.1046/j.1365-2133.1999.02974.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.